AnaptysBio, Inc. (ANAB) Balance Sheet
As of 2026-06-30 (10-KT), AnaptysBio, Inc. (ANAB) reported total assets of $317.0M and shareholders' equity of $10.6M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $133.8M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ANABAnaptysBio, Inc.Follow ANAB — free
—
Price chart with a free account
- Market cap
- 1.5B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | FY2026 Jun 26 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 81.2 | 113.6 | 171.0 | 250.5 | 495.7 | 71.3 | 36.0 | 23.1 | 138.2 | 133.8 | 133.8 | |
| Short-term investments | 167.2 | 313.5 | 203.2 | 143.2 | 52.4 | 369.9 | 354.9 | 262.3 | 73.4 | 30.3 | 30.3 | |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 | 1.4 | 6.9 | 40.8 | 33.9 | 25.6 | 25.6 | |
| Current assets | 252.7 | 434.2 | 377.7 | 396.6 | 553.9 | 447.2 | 406.8 | 431.9 | 350.3 | 198.4 | 198.4 | |
| Total assets | 329.4 | 509.0 | 435.2 | 416.6 | 643.1 | 610.4 | 452.4 | 483.8 | 364.4 | 317.0 | 317.0 | |
| Current liabilities | 14.1 | 21.8 | 29.5 | 19.8 | 16.1 | 26.1 | 37.4 | 45.4 | 38.6 | 35.4 | 35.4 | |
| Shareholders' equity | 307.6 | 486.4 | 405.0 | 396.7 | 356.4 | 262.1 | 88.1 | 70.9 | 37.2 | 10.6 | 10.6 |
USD millions · SEC XBRL
AnaptysBio, Inc. — questions
- How much cash does AnaptysBio, Inc. have?
- $133.8M in cash and cash equivalents as of 2026-06-30.
- What are AnaptysBio, Inc.'s total assets?
- $317.0M as of 2026-06-30.
- What is AnaptysBio, Inc.'s shareholders' equity?
- $10.6M as of 2026-06-30.
Every figure on this page comes from AnaptysBio, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.